[Federal Register: November 16, 2007 (Volume 72, Number 221)]
[Notices]
[Page 64673-64674]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr16no07-128]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated July 10, 2007, and published in the Federal
Register on July 24, 2007, (72 FR 40331-40332), Applied Science Labs,
Division of Alltech Associates Inc., 2701 Carolean Industrial Drive,
State College, Pennsylvania 16801, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
schedule I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methcathinone (1237)........................ I
N-Ethylamphetamine (1475)................... I
N,N-Dimethylamphetamine (1480).............. I
4-Methylaminorex (cis isomer) (1590)........ I
Alpha-ethyltryptamine (7249)................ I
Lysergic acid diethylamide (7315)........... I
2,5-Dimethoxy-4-n)-propylthiophenethylamine I
(2C-T-7) (7348).
Tetrahydrocannabinols (7370)................ I
Mescaline (7381)............................ I
4-Bromo-2,5-dimethoxyamphetamine (7391)..... I
4-Bromo-2,5-dimethoxyphenethylamine (7392).. I
4-Methyl-2,5-dimethoxyamphetamine (7395).... I
2,5-Dimethoxyamphetamine (7396)............. I
2-5-Dimethoxy-4-ethylamphetamine (7399)..... I
3,4-Methylenedioxyamphetamine (7400)........ I
N-Hydroxy-3,4-methylenedioxyamphetamine I
(7402).
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405).... I
4-Methoxyamphetamine (7411)................. I
Alpha-methyltryptamine (AMT) (7432)......... I
Bufotenine (7433)........................... I
Diethyltryptamine (7434).................... I
[[Page 64674]]
Dimethyltryptamine (7435)................... I
Psilocybin (7437)........................... I
Psilocyn (7438)............................. I
5-methoxy-N-,N-diisopropyltryptamine(5-MeO- I
DIPT) (7439).
N-Ethyl-1-phenylcyclohexylamine (7455)...... I
1[1-(2 Thienyl)cyclohexyl]piperidine (7470). I
1-(1-Phenylcyclohexyl)pyrrolidine (PCPy) I
(7458).
Dihydromorphine (9145)...................... I
Normorphine (9313).......................... I
Methamphetamine (1105)...................... II
1-Phenylcylohexylamine (7460)............... II
Phencyclidine (7471)........................ II
Phenylacetone (8501)........................ II
1-Piperidinocyclohexanecarbonitrile (8603).. II
Cocaine (9041).............................. II
Codeine (9050).............................. II
Dihydrocodeine (9120)....................... II
Benzoylecgonine (9180)...................... II
Meperidine intermediate-B (9233)............ II
Noroxymorphone (9668)....................... II
------------------------------------------------------------------------
The company plans to manufacture high purity drug standards used
for analytical application only in clinical, toxicological, and
forensic laboratories.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Applied Science Labs to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Applied Science Labs to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: November 5, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-22466 Filed 11-15-07; 8:45 am]
BILLING CODE 4410-09-P